Skip to main content
. 2020 Nov 11;40(46):8831–8841. doi: 10.1523/JNEUROSCI.1107-20.2020

Table 1.

SCI participantsa

Participant no. Age (yr) Gender AIS Level Etiology Time after injury (yr) Medication(s)
1 31 M A C5 T 12 None
2 62 M D C5 T 17 None
3 27 M A C1 T 4 BAC
4 34 F C C4 T 16 None
5 71 M C C2 T 8 BAC
6 38 M C C5 T 3 BAC
7 62 M D C1 NT 5 GBP
8 69 M C C2 T 11 GBP, TIZ
9 47 M C C5 T 3 BAC
10 33 M C C5 T 6 None
11 29 M A C4 T 3 None
12 22 M A C5 T 2 BAC
13 48 M D C6 T 12 None
14 27 M C C4 T 8 BAC, GBP
15 50 M D C5 T 1 BAC, GBP
16 24 M C C5 NT 1 None
17 60 F C C5 T 36 None
18 45 M C C4 T 11 None

aT, traumatic; NT, nontraumatic; BAC, baclofen; GBP, gabapentin; TIZ, tizanidine.